Linking transcriptomic and imaging data defines features of a favorable tumor immune microenvironment (TIME) and identifies a combination biomarker for primary melanoma

Patients with resected stage II-III melanoma have approximately a 35% chance of death from their disease. A deeper understanding of the tumor immune microenvironment (TIME) is required to stratify patients and identify factors leading to therapy resistance. We previously identified that the melanoma...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cancer Res
Egile Nagusiak: Gartrell-Corrado, Robyn D., Chen, Andrew X., Rizk, Emanuelle M., Marks, Douglas K., Bogardus, Margaret H., Hart, Thomas D., Silverman, Andrew M., Bayan, Claire-Audrey Y., Finkel, Grace G., Barker, Luke W., Komatsubara, Kimberly M., Carvajal, Richard D., Horst, Basil A., Chang, Rui, Monod, Anthea, Rabadan, Raul, Saenger, Yvonne M.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2020
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7112471/
https://ncbi.nlm.nih.gov/pubmed/31948941
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-19-2039
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak